[The differentiation of viruses in the Venezuelan equine encephalomyelitis complex by using monoclonal antibodies and lanthanide immunofluorescence analysis].

This research study investigates the potential to differentiate between Venezuelan equine encephalomyelitis (VEE) complex viruses using fluoroimmunoassay and enzyme immunoassay tests. The researchers used four test systems, based on different combinations of native and labeled antibodies. They discovered that the most sensitive and specific results were obtained using a particular combination of antibodies, which allowed them to differentiate between different variants of the disease.

Methodology

• The main approach to differentiate between Venezuelan equine encephalomyelitis (VEE) complex viruses was a bioanalytical technique involving time-resolved fluoroimmunoassay (a type of immunoassay that uses a fluorochrome for detection) and enzyme immunoassay.
• Four different test systems were utilized in the research, each using different combinations of native and labeled antibodies. Specifically, the antibodies in question were obtained from the VEE virus, strain Trinidad.
• The monoclonal antibody (MCA), MAK 14-7, which is specific to the EL protein of the virus, was also used.

Results and Findings

• The researchers found that the highest sensitivity and specificity were achieved in the test system that used native MCA MAK 14-7 to sensitize the solid phase and labeled polyclonal immunoglobulins to display the results.
• This specific combination of antibodies facilitated differentiation between the epidemic VEF/Trinidad (IA) strain of VEE and other disease variants such as Mucambo (III), Pixuna (IV), and an attenuated strain numbered 230.

Implications and Significance

• This research potentially marks an important stride in identifying the different strains of the VEE virus, which could have crucial implications for developing targeted treatments and vaccines.
• Improving testing sensitivity and specificity could lead to more accurate diagnoses, facilitating more effective treatments for these variants of the VEE virus.